Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tarsons ProductsNSE:TARSONS -2.12%82 Days Payable is 45.01 as of Mar. 2026, which is 5% above its 10-year median of 42.97. GuruFocus rates NSE:TARSONS with a GF Score™ of 82/100 and a GF Value™ of ₹568.53 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Tarsons Products ranks worse than 72.04% on this metric.
The historical rank and industry rank for Tarsons Products's Days Payable or its related term are showing as below:
NSE:TARSONS'
s Days Payable Range Over the Past 10 Years
Min: 11.8 Med: 42.97 Max: 52.71
Current: 43.94
During the past 8 years, Tarsons Products's highest Days Payable was 52.71. The lowest was 11.80. And the median was 42.97.
NSE:TARSONS's Days Payable is ranked worse than 72.04% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs NSE:TARSONS: 43.94
Tarsons Products's Days Payable
increased
from Mar. 2025 (37.83) to Mar. 2026 (45.01).
It may suggest that Tarsons Productsdelayed paying its suppliers.
Tarsons Products Days Payable Related Terms
Tarsons Products Days Payable Historical Data
* Premium members only.
The historical data trend for Tarsons Products's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:TARSONS vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Tarsons Products's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tarsons Products Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tarsons Products's Days Payable distribution charts can be found below:
* The bar in red indicates where Tarsons Products's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Tarsons Products's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tarsons Products (NSE:TARSONS) has a Days Payable of 45.01 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tarsons Products and its competitors. This is near median its historical median of 42.97. Over the past decade, Tarsons Products' Days Payable has ranged from 11.80 to 52.71. According to the industry distribution chart, Tarsons Products ranks #572 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 72%.
Is Tarsons Products' Days Payable too high?
Tarsons Products' current Days Payable of 45.01 is near median its 10-year median of 42.97. Over the past 10 years, this metric has ranged from a low of 11.80 to a high of 52.71. The Medical Devices & Instruments industry median Days Payable is 67.97. Tarsons Products' value of 45.01 is 33.8% below this industry median. Based on the distribution chart, Tarsons Products ranks #572 out of 794 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Tarsons Products has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tarsons Products' Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tarsons Products ranks #572 out of 794 companies for Days Payable. This places Tarsons Products in the lower half of its industry. The industry median Days Payable is 67.97. Tarsons Products' value of 45.01 is 33.8% below this benchmark. Historically, Tarsons Products' own Days Payable has ranged from 11.80 to 52.71 over the past decade. While the company's 10-year median is 42.97 vs. the industry median of 67.97, Tarsons Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tarsons Products's current Days Payable of 45.01 is 33.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tarsons Products and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tarsons Products's current Days Payable is 45.01, which is near median its own 10-year median of 42.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tarsons Products stock overvalued right now?
Based on GuruFocus' analysis, Tarsons Products (NSE:TARSONS) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹568.53, compared to a current price of ₹281.35 — trading 50.5% below its estimated fair value. The current Days Payable is 45.01, which is near median its 10-year median of 42.97 and 33.8% below the Medical Devices & Instruments industry median of 67.97. Tarsons Products' overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Tarsons Products (NSE:TARSONS), the current Days Payable is 45.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tarsons Products (NSE:TARSONS) Overvalued in 2026?
Based on GuruFocus' analysis, Tarsons Products stock appears to be undervalued.
The current stock price of ₹281.35 is trading 50.5% below its estimated GF Value™ of ₹568.53.
GuruFocus considers Tarsons Products to be Significantly Undervalued.
Key valuation signals for NSE:TARSONS:
Days Payable: 45.01 (near median its 10-year median of 42.97)
GF Value™: ₹568.53 vs. price of ₹281.35 (50.5% below fair value)
Industry Position: 33.8% below the Medical Devices & Instruments median (#572 of 794)
No single metric tells the full story. See the NSE:TARSONS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tarsons Products Ltd is an Indian labware Company engaged in designing, developing, manufacturing, and marketing consumables, reusables, and other including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies, and hospitals. The Company is also engaged in the manufacturing of a wide range of quality labware products that help scientific discovery and improve healthcare. The company generates the majority of its revenue from the sale of manufactured plastic products. Geographically, the company generates the majority of its revenue from India.
82GF Score
Get the complete analysis for NSE:TARSONS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TARSONS has been successfully added to your 
